September 18, 2008
'Forbes': Charities Drive Drug Development
By putting up money for clinical trials, investing in biotechnology companies, and assembling networks of doctors and patients who want to participate in research, health charities are helping to drive the development of new treatments — and becoming important players in the pharmaceutical industry, writes Forbes (September 15).
"By becoming a one-stop source for expertise and research about their disease, these patient groups can use as little as a few million
This content is only for subscribers. You can gain access by purchasing a:
Print Subscription
Digital Subscription
Already have an account? Log In Now.
Get more great stories about the nonprofit world delivered to your inbox every weekday. 
